Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
NEW YORK, April 29, 2022 (GLOBE NEWSWIRE) -- FMW Media’s New to The Street TV announces broadcasting its business show Saturday, April 30, 2022, on Bloomberg TV at 6:00 PM EST. New to The Street’s...
-
Leonardo SpA, LDO IM, ISIN IT0003856405, Milan Stock Exchange LONDON, April 29, 2022 (GLOBE NEWSWIRE) -- Bluebell Partners Ltd has submitted, at the AGM of Leonardo SpA, a proposal for liability...
-
NEW YORK, April 29, 2022 (GLOBE NEWSWIRE) -- FMW Media’s New To The Street / Newsmax TV announces the broadcasting lineup of its national syndicated 1- hour TV show this Sunday, May 01, 2022, airing...
-
MARLBOROUGH, Mass., April 29, 2022 (GLOBE NEWSWIRE) -- ReWalk Robotics, Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company"), a leading manufacturer of robotic medical technology for people with lower...
-
ENENTO GROUP PLC, STOCK EXCHANGE RELEASE ON 29 APRIL 2022 AT 3.30 P.M. EEST Enento Group Plc – Managers' transactions – CEO Jeanette Jäger____________________________________________ Person...
-
New interim TACTI-002 data from 2nd line metastatic non-small cell lung carcinoma (NSCLC) patients shows encouraging early overall survival rate of 73.7% at the six-month landmarkConstructive feedback...
-
TORONTO, April 29, 2022 (GLOBE NEWSWIRE) -- Galane Gold Ltd. (“Galane Gold” or the “Company”) (TSX-V: GG; OTCQB: GGGOF) is pleased to announce the release of its financial results for the year ended...
-
Pune, April 29, 2022 (GLOBE NEWSWIRE) -- "Final Report will add the analysis of the impact of COVID-19 on this industry." The global “Proteomics Market” 2022-2027 study provides critical...
-
Résultats annuels 2021Chiffre d’affaires du 1er trimestre 2022 Lancement début avril de la version 6.6 d’XpertEye Accélération commerciale au 2ème trimestre pour déployer cette nouvelle version AMA...
-
REGULATED INFORMATION Strategic focus revised and fully focused on achieving topline results of the ALLOB Phase IIb study in tibial fractures. Discussions for ALLOB global partnership still...